BioCentury | Sep 8, 2020
Finance

Algenex raises €7.4 million C round, looks to partner manufacturing platform with COVID-19 vaccine developers

...manufacturing technology, which could provide a cheaper and faster platform for producing vaccine antigens.On Tuesday Algenex S.L....
...bottlenecks for COVID-19 vaccine development and commercialization (see “Merck’s Gerberding Advocates for a Head Start”). Stephen Hansen Algenex S.L. cov19count cov19count...
Items per page:
1 - 1 of 1
BioCentury | Sep 8, 2020
Finance

Algenex raises €7.4 million C round, looks to partner manufacturing platform with COVID-19 vaccine developers

...manufacturing technology, which could provide a cheaper and faster platform for producing vaccine antigens.On Tuesday Algenex S.L....
...bottlenecks for COVID-19 vaccine development and commercialization (see “Merck’s Gerberding Advocates for a Head Start”). Stephen Hansen Algenex S.L. cov19count cov19count...
Items per page:
1 - 1 of 1